Lisa Utzschneider Sells 8,044 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 8,044 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the completion of the transaction, the chief executive officer now directly owns 203,139 shares in the company, valued at $2,025,295.83. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Lisa Utzschneider also recently made the following trade(s):

• On Monday, April 8th, Lisa Utzschneider sold 30,407 shares of Integral Ad Science stock. The shares were sold at an average price of $10.05, for a total transaction of $305,590.35.

Integral Ad Science Stock Performance

NASDAQ IAS opened at $8.37 on Thursday. The company has a current ratio of 3.21, a quick ratio of 3.21 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $1.34 billion, a price-to-earnings ratio of 206.05, a P/E/G ratio of 1.72 and a beta of 1.58. The firm’s 50 day simple moving average is $9.70 and its 200 day simple moving average is $12.84. Integral Ad Science Holding Corp. has a 1 year low of $7.98 and a 1 year high of $20.88.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.03. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The business had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. During the same quarter last year, the business posted $0.07 EPS. The firm’s revenue for the quarter was up 14.4% on a year-over-year basis. As a group, research analysts expect that Integral Ad Science Holding Corp. will post 0.16 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

IAS has been the topic of several research analyst reports. Raymond James cut shares of Integral Ad Science from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $20.00 to $16.00 in a report on Wednesday, February 28th. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research report on Tuesday. Oppenheimer decreased their target price on shares of Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Piper Sandler decreased their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 28th. Finally, Morgan Stanley restated an “equal weight” rating and set a $12.00 target price (down previously from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $17.38.

Institutional Trading of Integral Ad Science

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Integral Ad Science by 10.7% during the fourth quarter. Vanguard Group Inc. now owns 8,106,247 shares of the company’s stock valued at $116,649,000 after acquiring an additional 780,469 shares during the last quarter. Clearbridge Investments LLC raised its stake in shares of Integral Ad Science by 6.5% during the fourth quarter. Clearbridge Investments LLC now owns 3,494,608 shares of the company’s stock valued at $50,287,000 after acquiring an additional 214,693 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in shares of Integral Ad Science by 9.9% during the first quarter. TimesSquare Capital Management LLC now owns 2,969,278 shares of the company’s stock valued at $29,604,000 after acquiring an additional 268,310 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Integral Ad Science by 605.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock valued at $39,429,000 after acquiring an additional 2,351,414 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Integral Ad Science by 10.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,377,272 shares of the company’s stock valued at $34,212,000 after acquiring an additional 222,614 shares during the last quarter. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.